Cart
sales@molnova.com
Lorglumide sodium salt
CAS No. 1021868-76-7
Lorglumide sodium salt( CR-1409 sodium salt )
Catalog No. M26280 CAS No. 1021868-76-7
Lorglumide sodium salt is a potent cholecystokinin (CCK) receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 42 | Get Quote |
|
| 10MG | 65 | Get Quote |
|
| 25MG | 107 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLorglumide sodium salt
-
NoteResearch use only, not for human use.
-
Brief DescriptionLorglumide sodium salt is a potent cholecystokinin (CCK) receptor antagonist.
-
DescriptionLorglumide sodium salt is a potent cholecystokinin (CCK) receptor antagonist.
-
In Vitro——
-
In Vivo——
-
SynonymsCR-1409 sodium salt
-
PathwayGPCR/G Protein
-
TargetCholecystokinin Receptor
-
RecptorPEGs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1021868-76-7
-
Formula Weight481.39
-
Molecular FormulaC22H31Cl2N2NaO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (207.73 mM)
-
SMILESCCCCCN(CCCCC)C(=O)C(CCC(=O)O[Na])NC(=O)c1ccc(Cl)c(Cl)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
molnova catalog
related products
-
WAY-620645
WAY-620645 is a CCK antagonist with antitumor and analgesic activities.
-
CE-326597
A potent, selective agonist of the human and rat CCK1 receptor with Ki of 36 nM.
-
Spiroglumide
Spiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be used to explore the physiological role of gastrin in the regulation of human gastric acid secretion.
